Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  leuprolide acetate
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-25 of 100 for your search:
Start Over
Randomized Crossover Trial to Assess the Tolerability of Gonadotropin Releasing Hormone (GnRH) Analogue Administration
Phase: Phase IV
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: TRE1001, NCT01161563
GP Extended Action Triptorelin
Phase: Phase IV
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: A-97-52014-181, 2011-004213-16, NCT01673984
A Study in Patients With Metastatic Prostate Cancer to Assess How the Drug Eligard®, Affects Certain Markers in Blood and Urine, Which Are Indicators for the Disease
Phase: Phase IV
Type: Biomarker/Laboratory analysis, Treatment
Status: Temporarily closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: EGD-EC-005, 2012-000101-69, NCT01933022
Phase III Randomized Study of Adjuvant Tamoxifen with vs without Ovarian Ablation in Premenopausal Women with Axillary Node-Negative Receptor-Positive Breast Cancer 3 cm or Less in Diameter (Summary Last Modified 03/98)
Phase: Phase III
Type: Treatment
Status: Completed
Age: premenopausal
Sponsor: NCI
Protocol IDs: E-3193, CLB-9494, NCCTG-933252, SWOG-9347, INT-0142, E3193
Radiation Therapy With or Without Antiandrogen Therapy in Treating Patients With Stage I or Stage II Prostate Cancer
Phase: Phase III
Type: Treatment
Status: Completed
Age: Any age
Sponsor: NCI, Other
Protocol IDs: RTOG-9408, CDR0000063821, NCT00002597
Phase III Randomized Study of Orchiectomy or LHRH Analogue Plus Flutamide With or Without Suramin and Hydrocortisone in Advanced Adenocarcinoma of the Prostate
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: E-8892, CLB-E8892, SWOG-E8892, NCT00002881, E8892
Hormone Therapy in Treating Patients Who Have Stage I or Stage II Prostate Cancer
Phase: Phase III
Type: Treatment
Status: Closed
Age: Not specified
Sponsor: NCI, Other
Protocol IDs: ID97-077, P30CA016672, MDA-ID-97077, E-97077, NCI-T97-0069, CDR0000066733, NCI-2009-00818, T97-0069, NCT00003645
Thalidomide for the Treatment of Hormone-Dependent Prostate Cancer
Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: 000080, 00-C-0080, NCI-00-C-0080, NCI-T99-0053, T99-0053, NCT00020085, NCT00004635
Phase III Randomized Comparison of Leuprolide/Flutamide vs Leuprolide Alone in Previously Untreated Patients with Stage D2 Adenocarcinoma of the Prostate
Phase: Phase III
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-8494, MAOP-4384, NCCTG-INT-0036, NCOG-4P842J, NPCTG-2200, INT-0036
Phase III Randomized Comparison of Leuprolide/Anandron vs Leuprolide/Placebo in Patients with Stage D2 Carcinoma of the Prostate
Phase: Phase III
Type: Treatment
Status: Completed
Age: 40 to 85
Sponsor:
Protocol IDs: FCCC-86814, NCI-V87-0282
Hormone Therapy With or Without Docetaxel And Estramustine in Treating Patients With Prostate Cancer That is Locally Advanced or At High Risk of Relapse
Phase: Phase III
Type: Treatment
Status: Closed
Age: Under 80
Sponsor: Other
Protocol IDs: CDR0000270970, FRE-FNCLCC-GETUG-12/0203, EU-20238, NCT00055731
Zoledronate in Preventing Skeletal (Bone)-Related Events in Men Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000353209, U10CA031946, CALGB-90202, CAN-NCIC-PRC2, ECOG-CALGB-90202, SWOG-CALGB-90202, NCT00079001
Clinical Trial for Prostate Cancer
Phase: Phase III
Type: Treatment
Status: Completed
Age: 40 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: OL-007, NCT00076531
Leuprolide Acetate 3.75 mg Depot to Treat Prostate Cancer
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CRO-04-62, NCT00128531
RADAR Trial - Randomised Androgen Deprivation and Radiotherapy
Phase: Phase III
Type: Supportive care, Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: TROG 03.04, ACTRN12607000097448, NCT00193856
Start Over